355 related articles for article (PubMed ID: 26886388)
1. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.
Misra DP; Shenoy SN
Rheumatol Int; 2017 Jan; 37(1):151-167. PubMed ID: 26886388
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Manifestations of Systemic Vasculitides.
Silveira LH
Curr Rheumatol Rep; 2020 Aug; 22(10):72. PubMed ID: 32856161
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
[TBL] [Abstract][Full Text] [Related]
4. Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis.
Sangle SR; Davies RJ; Mora M; Baron MA; Hughes GR; D'Cruz DP
Rheumatology (Oxford); 2008 Jul; 47(7):1058-60. PubMed ID: 18499719
[TBL] [Abstract][Full Text] [Related]
5. Cardiac involvement and cardiovascular risk factors in pediatric primary systemic vasculitides.
Sener S; Arslanoglu Aydin E; Batu ED
Clin Rheumatol; 2023 Mar; 42(3):673-686. PubMed ID: 36369404
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides.
Cohen Tervaert JW
Best Pract Res Clin Rheumatol; 2013 Feb; 27(1):33-44. PubMed ID: 23507055
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk in vasculitis.
Misra DP; Sharma A; Karpouzas GA; Kitas GD
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101831. PubMed ID: 37302927
[TBL] [Abstract][Full Text] [Related]
8. The lung in systemic vasculitis: radiological patterns and differential diagnosis.
Feragalli B; Mantini C; Sperandeo M; Galluzzo M; Belcaro G; Tartaro A; Cotroneo AR
Br J Radiol; 2016; 89(1061):20150992. PubMed ID: 26876879
[TBL] [Abstract][Full Text] [Related]
9. Thrombo-embolic and vascular complications in vasculitis syndromes.
Somer T
Eur Heart J; 1993 Dec; 14 Suppl K():24-9. PubMed ID: 7907547
[TBL] [Abstract][Full Text] [Related]
10. Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis.
Schmidt J; Pulido JS; Matteson EL
Curr Opin Ophthalmol; 2011 Nov; 22(6):489-95. PubMed ID: 21918443
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular involvement in Behçet's disease].
Desbois AC; Wechsler B; Cluzel P; Helft G; Boutin D; Piette JC; Cacoub P; Saadoun D
Rev Med Interne; 2014 Feb; 35(2):103-11. PubMed ID: 24434015
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac involvement in Churg-Strauss syndrome].
Brucato A; Maestroni S; Masciocco G; Ammirati E; Bonacina E; Pedrotti P
G Ital Cardiol (Rome); 2015 Sep; 16(9):493-500. PubMed ID: 26418389
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis in vasculitis.
Springer J; Villa-Forte A
Curr Opin Rheumatol; 2013 Jan; 25(1):19-25. PubMed ID: 23143223
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological therapy of vasculitis: an update.
Uthman I
Curr Opin Pharmacol; 2004 Apr; 4(2):177-82. PubMed ID: 15063363
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.
Lenert A; Lenert P
Drug Des Devel Ther; 2015; 9():333-47. PubMed ID: 25609919
[TBL] [Abstract][Full Text] [Related]
16. B-cell-targeted therapy in systemic vasculitis.
Lally L; Spiera R
Curr Opin Rheumatol; 2016 Jan; 28(1):15-20. PubMed ID: 26599379
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular involvement in primary systemic vasculitis.
Mukhtyar C; Brogan P; Luqmani R
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):419-28. PubMed ID: 19508948
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis in vasculitis.
Gaffo AL
Best Pract Res Clin Rheumatol; 2013 Feb; 27(1):57-67. PubMed ID: 23507057
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Disease in the Systemic Vasculitides.
Soulaidopoulos S; Madenidou AV; Daoussis D; Melissaropoulos K; Mavrogeni S; Kitas G; Dimitroulas T
Curr Vasc Pharmacol; 2020; 18(5):463-472. PubMed ID: 32000652
[TBL] [Abstract][Full Text] [Related]
20. [Vasculitides of the coronary arteries].
Stvrtinová V
Bratisl Lek Listy; 1995 Oct; 96(10):544-51. PubMed ID: 8620325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
